23 May 2025 - New treatment sparsentan has been found to slow down the progression of kidney damage, which will change ...
22 May 2025 - Genentech announced today that the US FDA has approved Susvimo (ranibizumab injection) 100 mg/mL for the treatment ...
22 May 2025 - Approval based on the positive MATINEE and METREX Phase 3 trials. ...
22 May 2025 - Dostarlimab, when used in combination with platinum-based chemotherapy, can be used as an option for the ...
22 May 2025 - A new drug to treat the early stages of Alzheimer’s disease has been approved for use ...
21 May 2025 - Based on LAURA Phase 3 trial results which showed patients who took Targrisso after CRT had ...
21 May 2025 - The authorisation in Australia is for adult patients who are Apolipoprotein E-ε4 heterozygotes or non-carriers. ...
19 May 2025 - Bayer announced that the US FDA has approved Jivi, a recombinant DNA-derived, extended half-life factor VIII ...
19 May 2025 - Nuvaxovid is the only recombinant protein-based, non-mRNA COVID-19 vaccine available in the US. ...
16 May 2025 - New test provides less invasive option, reduces reliance on PET scans and increases diagnosis accessibility. ...
16 May 2025 - The MHRA has today approved guselkumab (Tremfya) to treat Crohn’s disease and ulcerative colitis. ...
15 May 2025 - The MHRA has today approved a vaccine (Capvaxive) for people aged 18 years and older to help ...
16 May 2025 - Approval based on results from the CheckMate-77T trial which showed perioperative Opdivo improved event-free survival compared ...
15 May 2025 - Product will be available for appropriate patients in the second half of 2025 ...
15 May 2025 - Independent appraisal committee voted that current evidence is adequate to demonstrate a net health benefit of ...